Cambridge Investment Research Advisors’s FT Vest U.S. Equity Max Buffer ETF - September SEPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Sell
6,438
-7,092
-52% -$230K ﹤0.01% 3784
2026
Q1
$428K Hold
13,530
﹤0.01% 2945
2025
Q4
$430K Buy
13,530
+70
+0.5% +$2.21K ﹤0.01% 2870
2025
Q3
$423K Buy
13,460
+3,115
+30% +$97K ﹤0.01% 2819
2025
Q2
$319K Hold
10,345
﹤0.01% 2931
2025
Q1
$308K Sell
10,345
-18
-0.2% -$539 ﹤0.01% 2847
2024
Q4
$309K Buy
10,363
+333
+3% +$9.91K ﹤0.01% 2806
2024
Q3
$297K Buy
+10,030
New +$297K ﹤0.01% 2840

Other funds holding SEPM

Cambridge Investment Research Advisors's SEPM Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its FT Vest U.S. Equity Max Buffer ETF - September (SEPM) stake by 52% in Q2 2026, selling an estimated $230K and leaving 6,438 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #3784.

Cambridge Investment Research Advisors first reported a position in SEPM in Q3 2024 and has held it in 8 quarters since. The position peaked at $430K in Q4 2025. 18 funds tracked by Wall St. Rank hold SEPM as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,438 shares of FT Vest U.S. Equity Max Buffer ETF - September worth $211K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 7,092 FT Vest U.S. Equity Max Buffer ETF - September shares in Q2 2026, an estimated $230K.
  • FT Vest U.S. Equity Max Buffer ETF - September made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3784 holding.
  • Cambridge Investment Research Advisors first reported a position in FT Vest U.S. Equity Max Buffer ETF - September in Q3 2024 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's FT Vest U.S. Equity Max Buffer ETF - September position peaked at $430K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - September as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.